Low CD34+ Cell Doses Are Associated with Increased Cost and Worse Outcome after Tandem Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Germ Cell Tumors.
Biol Blood Marrow Transplant
; 24(7): 1497-1504, 2018 07.
Article
in En
| MEDLINE
| ID: mdl-29410296
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Transplantation, Autologous
/
Neoplasms, Germ Cell and Embryonal
/
Hematopoietic Stem Cell Transplantation
/
Antigens, CD34
Type of study:
Health_economic_evaluation
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Biol Blood Marrow Transplant
Journal subject:
HEMATOLOGIA
/
TRANSPLANTE
Year:
2018
Document type:
Article